These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 6232993)
41. Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study. Ross HJ; Gullestad L; Pak J; Slauson S; Valantine HA; Hunt SA J Heart Lung Transplant; 1997 Feb; 16(2):179-89. PubMed ID: 9059929 [TBL] [Abstract][Full Text] [Related]
42. Reduced infection in cardiac transplant recipients. Dresdale AR; Drusin RE; Lamb J; Smith CR; Reemtsma K; Rose EA Circulation; 1985 Sep; 72(3 Pt 2):II237-40. PubMed ID: 3896557 [TBL] [Abstract][Full Text] [Related]
43. Late acute cardiac allograft rejection: new therapeutic options? Schweiger M; Wasler A; Prenner G; Tripolt M; Schwarz M; Tscheliessnigg KH Transplant Proc; 2005 Dec; 37(10):4528-31. PubMed ID: 16387161 [TBL] [Abstract][Full Text] [Related]
44. Triple-drug immunosuppression for heart transplantation in infants and children. Brown JW; Turrentine MW; Kesler KA; Mahomed Y; Darragh R; Evans K; Thompson L; Caldwell R J Heart Lung Transplant; 1993; 12(6 Pt 2):S265-74. PubMed ID: 8312346 [TBL] [Abstract][Full Text] [Related]
45. Left ventricular dysfunction after heart transplantation: incidence and role of enhanced immunosuppression. McNamara D; Di Salvo T; Mathier M; Keck S; Semigran M; Dec GW J Heart Lung Transplant; 1996 May; 15(5):506-15. PubMed ID: 8771506 [TBL] [Abstract][Full Text] [Related]
47. Is 3-hour cyclosporine blood level superior to trough level in early post-renal transplantation period? Mahalati K; Lawen J; Kiberd B; Belitsky P J Urol; 2000 Jan; 163(1):37-41. PubMed ID: 10604309 [TBL] [Abstract][Full Text] [Related]
48. Cyclosporine C2 target levels and acute cellular rejection after lung transplantation. Glanville AR; Aboyoun CL; Morton JM; Plit M; Malouf MA J Heart Lung Transplant; 2006 Aug; 25(8):928-34. PubMed ID: 16890113 [TBL] [Abstract][Full Text] [Related]
49. Outcome of renal transplantation subsequent to liver, heart, or lung transplantation. Tarnow H; Herlenius G; Friman S; Olausson M; Nordén G; Felldin M; Bäckman L Transplant Proc; 2006 Oct; 38(8):2649-50. PubMed ID: 17098027 [TBL] [Abstract][Full Text] [Related]
50. Alternate-day prednisone in the maintenance immunosuppressive therapy after orthotopic liver transplantation. Pedrosa MC; Rohrer RM; Kaplan MM Clin Transplant; 1995 Aug; 9(4):322-5. PubMed ID: 7579741 [TBL] [Abstract][Full Text] [Related]
51. Cytoimmunologic monitoring after heart and heart-lung transplantation. May RM; Cooper DK; Du Toit ED; Reichart B J Heart Transplant; 1990; 9(2):133-5. PubMed ID: 2319372 [TBL] [Abstract][Full Text] [Related]
52. Cyclosporine: a new immunosuppressive agent for organ transplantation. Cohen DJ; Loertscher R; Rubin MF; Tilney NL; Carpenter CB; Strom TB Ann Intern Med; 1984 Nov; 101(5):667-82. PubMed ID: 6385799 [TBL] [Abstract][Full Text] [Related]
53. Prevention of toxic side effects of cyclosporine in heart transplantation. Schüler S; Warnecke H; Hetzer R Transplant Proc; 1987 Feb; 19(1 Pt 3):2518-21. PubMed ID: 3547936 [No Abstract] [Full Text] [Related]
54. [Follow-up of heart transplants]. Mosseri M; Admon D; Yarom R; Rosenheck S; Gotsman MS Harefuah; 1989 Jan; 116(1):17-21. PubMed ID: 2651234 [TBL] [Abstract][Full Text] [Related]